Cue Biopharma, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Jul 22, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | May 14, 2026 · D | Jul 22, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $29,999,992 | $49,999,927 | $19,999,935 |
| Reported amount sold | $29,999,992 | $49,999,927 | $19,999,935 |
| Reported investor count | — | 4 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001645460-26-000003 · Later SEC source: 0001645460-26-000004
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $49,999,927
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $49,999,927
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Infinite Conferencing Partners, LLC · CIK 1662534
- Modular Medical, Inc. · CIK 1074871
Form D filings (2)
-
0001645460-26-000004D · Jul 22, 2026 · BiotechnologyOffering: $49,999,927Sold: $49,999,927
Compared with 0001645460-26-000003:
- Reported offering amount: $29,999,992 → $49,999,927
- Reported amount sold: $29,999,992 → $49,999,927
- Reported investor count: Unavailable → 4
-
0001645460-26-000003D · May 14, 2026 · BiotechnologyOffering: $29,999,992Sold: $29,999,992